2-APB
CAS No. 524-95-8
2-APB( —— )
Catalog No. M18729 CAS No. 524-95-8
2-Aminoethoxydiphenyl borate (2-APB) is a chemical that acts to inhibit both IP3 receptors and TRP channels (although it activates TRPV1, TRPV2, & TRPV3 at higher concentrations).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 34 | In Stock |
|
10MG | 47 | In Stock |
|
25MG | 74 | In Stock |
|
50MG | 111 | In Stock |
|
100MG | 177 | In Stock |
|
500MG | 440 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2-APB
-
NoteResearch use only, not for human use.
-
Brief Description2-Aminoethoxydiphenyl borate (2-APB) is a chemical that acts to inhibit both IP3 receptors and TRP channels (although it activates TRPV1, TRPV2, & TRPV3 at higher concentrations).
-
Description2-Aminoethoxydiphenyl borate (2-APB) is a chemical that acts to inhibit both IP3 receptors and TRP channels (although it activates TRPV1, TRPV2, & TRPV3 at higher concentrations).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTRPV1|TRPV2|TRPV3|TRPC6|TRPM8|IP3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number524-95-8
-
Formula Weight225.09
-
Molecular FormulaC14H16BNO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1110.67 mM)
-
SMILESNCCOB(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bai et al (2006) Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB). J.Pharmacol.Exp.Ther. 319 1452
molnova catalog
related products
-
A-71915 TFA (132956-...
A-71915 (TFA) is a selective inhibitor of ANP receptor (atrial natriuretic peptide-receptor), induces apoptosis and decreases insulin secretion in RINm5F pancreatic β-cells.
-
3-Amino-5-methylisox...
Pharmaceutical intermediates. Used in the production of sulfonamide drugs.
-
Maltotriose
Maltotriose is a common oligosaccharide metabolite found in human urine after maltose ingestion or infusion. Maltotriose is increased in Glycogen storage disease II due to a mutation of the enzyme alpha-14-glucosidase.